EMBL Ventures
Venture capitalHeidelberg · Seed–Late Stage · 1 people tracked
Find your way into EMBL Ventures
35 people in our graph share verified history with the EMBL Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
EMBL Ventures invests in life science companies throughout Europe, aiming to build businesses with significant commercial potential in areas such as new therapeutic treatment modalities and pharmaceuticals, next-generation enabling technology platforms, and innovations in diagnostics and medical devices. The firm draws on a strong scientific and life science industry network, an established investment track record, and experience building companies, structuring collaboration and licensing agreements, and executing M&A and IPOs. Portfolio companies receive hands-on support, access to the firm's network, and unique access to the EMBL, which the firm views as a source of added value.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from curated
What they invest in
from 2 of 10 portfolio companiesBiotech ×2Healthtech ×2Medical Devices ×1
HQs:Germany×1United States×1
Investments · 10 tracked
founders shown can be your intro path
Topas Therapeutics develops nanoparticle-based therapies to induce immune tolerance for autoimmune and immune-mediated diseases.
BiotechHealthtech
Hugo Fry(Chief Executive Officer)inChristian Schröter(Chief Operating Officer)Cristina de Min(Chief Medical Officer)Anne Burger(Chief Financial Officer)Alex Marshall(Chief Business Officer)in
Co-investorsBoehringer Ingelheim Venture FundGimvBioMedPartnersEpidarex Capital
Crescendo Biologics develops novel immune cell-enhancing therapeutics for immuno-oncology using its patent-protected Humabody VH platform, a fully human domain technology clinically validated in oncology and immunology.
BiotechHealthtechMedical Devices
Co-investorsAndera PartnersQuan CapitalSofinnova PartnersAstellas Venture Management LLCFuture Planet CapitalAvlar BioVentures+1 more
MIG portfolio company taken public.
Harpreet Singh(Founder)in
Co-investorsGrazia Equity GmbHMIG Capital AG
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Allecra TherapeuticsAmphivenaApellis PharmaceuticalsArsanisLuxendoOpsona TherapeuticsViraTherapeutics
Exits · 3
IPOs and acquisitions across the tracked portfolioApellis Pharmaceuticalsacq. by BiogenLuxendoacq. by BrukerViraTherapeuticsacq. by Boehringer Ingelheim
Portfolio news
latest coverage across their companies
Immatics · stocktitan.net · Aug 25, 2026
Frequently asked questions
- How many investments has EMBL Ventures made?
- EMBL Ventures has 10 tracked investments, 2 of which have exited via acquisition or IPO.
- What stage does EMBL Ventures invest at?
- EMBL Ventures invests at the Seed, Series A, Late Stage stages.
- What is EMBL Ventures's typical check size?
- EMBL Ventures typically writes checks of $108K – $5.4M.
- What sectors does EMBL Ventures focus on?
- EMBL Ventures focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
- Where is EMBL Ventures located?
- EMBL Ventures is headquartered in Heidelberg, DE.
- Who does EMBL Ventures co-invest with?
- EMBL Ventures most often shares deals with Epidarex Capital, BioMedPartners, Future Planet Capital, among 10 tracked co-investors.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.